HTML Microdata document

This HTML5 document contains 47 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
rdfs	http://www.w3.org/2000/01/rdf-schema#
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
owl	http://www.w3.org/2002/07/owl#
nci	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
xsdh	http://www.w3.org/2001/XMLSchema#

Statements

Subject Item: nci:C63779
rdf:type: owl:Class
rdfs:label: EPOCH Regimen
rdfs:subClassOf: nci:C63442 _:vb669104 _:vb669105 _:vb669106 _:vb669100 _:vb669101 _:vb669102 _:vb669103
nci:P106: Therapeutic or Preventive Procedure
nci:P108: EPOCH Regimen
nci:P207: C1880475
nci:P329: 38921
nci:P330: 38921
nci:P366: EPOCH_Regimen
nci:P90: <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>EPOCH</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000635788</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>EPOCH regimen</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000635788</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Dose-adjusted Etoposide/Vincristine/Doxorubicin/Cyclophosphamide/Prednisone Regimen</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>EPOCH Regimen</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin Regimen</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>EPOCH Regimen</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source><n0:source-code>TCGA</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>DA-EPOCH</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
nci:P97: <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin) and doxorubicin hydrochloride (hydroxydaunorubicin hycrochloride), which may be used in combination with rituximab (R-EPOCH) for the treatment of various aggressive B cell and T cell non-Hodgkin lymphomas.</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:P98: Source: Physician's Cancer Chemotherapy Drug Manual 2006
nci:code: C63779

Subject Item: _:vb669100
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C770

Subject Item: _:vb669101
rdf:type: owl:Restriction
owl:onProperty: nci:R172
owl:someValuesFrom: nci:C3211

Subject Item: _:vb669102
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C456

Subject Item: _:vb669103
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C491

Subject Item: _:vb669104
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C405

Subject Item: _:vb669105
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C933

Subject Item: _:vb669106
rdf:type: owl:Restriction
owl:onProperty: nci:R172
owl:someValuesFrom: nci:C4337